Karen M. Winkfield, MD, PhD
Articles by Karen M. Winkfield, MD, PhD
ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma
ByKaren M. Winkfield, MD, PhD,Ranjana H. Advani, MD,Leslie K. Ballas, MD,Bouthaina S. Dabaja, MD,Sughosh Dhakal, MD,Christopher R. Flowers, MD, MS,Chul Soo Ha, MD,Bradford S. Hoppe, MD, MPH,David B. Mansur, MD,Nancy P. Mendenhall, MD,Monika L. Metzger, MD,John P. Plastaras, MD, PhD,Kenneth B. Roberts, MD,Ronald Shapiro, MD,Sonali M. Smith, MD,Stephanie A. Terezakis, MD,Anas Younes, MD,Louis S. Constine, MD By combining the most recent medical literature and expert opinion, this revised guideline can aid clinicians in the complex decision-making associated with the management of recurrent Hodgkin lymphoma.
ACR Appropriateness Criteria® Localized Nodal Indolent Lymphoma
ByBradford S. Hoppe, MD, MPH,David C. Hodgson, MD,Ranjana H. Advani, MD,Bouthaina S. Dabaja, MD,Christopher R. Flowers, MD, MS,Chul Soo Ha, MD,Monika L. Metzger, MD,John P. Plastaras, MD, PhD,Kenneth B. Roberts, MD,Ronald Shapiro, MD,Stephanie A. Terezakis, MD,Karen M. Winkfield, MD, PhD,Anas Younes, MD,Louis S. Constine, MD The present guidelines review epidemiology, pathology, presentation, workup, staging, prognostic factors, and treatment options for patients with localized nodal indolent lymphoma, with an emphasis on radiation guidelines, including radiation dose, field design, and radiation techniques.
Breast cancer is the most commonly diagnosed cancer among women in the United States.[1] Since the early 1990s, breast cancer mortality has steadily declined,[2] and statistical modeling using a Bayesian approach attributes these declining mortality rates to both earlier diagnosis and more effective treatments.[3]
